TrialAnnals of the rheumatic diseases2015

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

Hermine I Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.